Worck, René http://orcid.org/0000-0001-9501-6168
Sørensen, Samuel K. http://orcid.org/0000-0001-8134-2245
Johannessen, Arne http://orcid.org/0000-0003-0294-3750
Ruwald, Martin H. http://orcid.org/0000-0002-1541-309X
Hansen, Morten Lock
Haugdal, Martin
Hansen, Jim http://orcid.org/0000-0001-6600-9006
Funding for this research was provided by:
Biosense Webster
Article History
Received: 12 September 2022
Accepted: 17 October 2022
First Online: 3 November 2022
Declarations
:
: The study was approved by the Danish National Science Ethics Committee (H15015153) and posted in a clinical trial database, ExternalRef removed (NCT05045131). All participants provided written informed consent.
: Dr. Worck has received research grants and speaker honoraria from Biosense Webster. Dr. Sørensen has received research grants from Medtronic and Biosense Webster. Dr. Lock Hansen has received research grants from the Novo Nordisk Foundation and Dr. Hansen has received research grants and speaker honoraria from Medtronic, Biosense Webster, and Boston Scientific. Dr Johannesen, Dr. Ruwald, and Mr. Haugdal have nothing to disclose. There are no other potentially competing interests to declare.